BCWORLD PHARM Return On Asset vs. Number Of Employees

200780 Stock  KRW 4,825  10.00  0.21%   
Taking into consideration BCWORLD PHARM's profitability measurements, BCWORLD PHARM Co may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in March. Profitability indicators assess BCWORLD PHARM's ability to earn profits and add value for shareholders.
For BCWORLD PHARM profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BCWORLD PHARM to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BCWORLD PHARM Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BCWORLD PHARM's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BCWORLD PHARM Co over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between BCWORLD PHARM's value and its price as these two are different measures arrived at by different means. Investors typically determine if BCWORLD PHARM is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BCWORLD PHARM's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

BCWORLD PHARM Number Of Employees vs. Return On Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining BCWORLD PHARM's current stock value. Our valuation model uses many indicators to compare BCWORLD PHARM value to that of its competitors to determine the firm's financial worth.
BCWORLD PHARM Co is rated fourth in return on asset category among its peers. It is rated third in number of employees category among its peers creating about  26,636  of Number Of Employees per Return On Asset. Comparative valuation analysis is a catch-all model that can be used if you cannot value BCWORLD PHARM by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BCWORLD PHARM's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

BCWORLD Number Of Employees vs. Return On Asset

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

BCWORLD PHARM

Return On Asset

 = 

Net Income

Total Assets

 = 
0.011
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

BCWORLD PHARM

Number of Employees

 = 

Full Time

+

Part Time

 = 
293
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.

BCWORLD Number Of Employees vs Competition

BCWORLD PHARM Co is rated third in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 1,347. BCWORLD PHARM totals roughly 293 in number of employees claiming about 22% of equities under Health Care industry.

BCWORLD Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on BCWORLD PHARM. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BCWORLD PHARM position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BCWORLD PHARM's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in BCWORLD PHARM without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

Use Investing Themes to Complement your BCWORLD PHARM position

In addition to having BCWORLD PHARM in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Junk Bonds Funds Thematic Idea Now

Junk Bonds Funds
Junk Bonds Funds Theme
Funds or Etfs that invest most of their assets into speculative (junk) bonds or to other fixed income instruments with interest rates 3 to 4 percentage points above government issues. The Junk Bonds Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Junk Bonds Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in BCWORLD Stock

To fully project BCWORLD PHARM's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BCWORLD PHARM at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BCWORLD PHARM's income statement, its balance sheet, and the statement of cash flows.
Potential BCWORLD PHARM investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although BCWORLD PHARM investors may work on each financial statement separately, they are all related. The changes in BCWORLD PHARM's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BCWORLD PHARM's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.